MedCity News July 18, 2019
Alaric DeArment

Silicon Valley Bank released its healthcare investments and exits trend report for the first half of 2019. It shows, among other things, oncology losing its first-place status in terms of Series A dollars raised.

Venture capital fundraising this year by biopharma startups is on course to fall behind last year, though it will be above the figure for 2017. But the biggest story may be where that funding is going.

Silicon Valley Bank released its 2019 midyear report, “Trends in Healthcare Investments and Exits 2019,” on Thursday. So far, healthcare companies have raised $5.8 billion in the first half of this year, compared with $9.6 billion for all of 2018 and $9.1 billion in 2017.

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Market Research, Pharma, Precision Medicine, Technology, Trends
Ilant Health Raises Extended Seed Round of $5.5M for Obesity Management Platform
Podcast: The State of Antitrust & Private Equity in Health Care w/ Brent Fulton
Metsera lands with $290m to take on obesity giants
Private equity bankruptcies in healthcare explode 112% in 5 years
California’s AB 3129: A New Hurdle for Private Equity Health Care Transactions on the Horizon?

Share This Article